Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Joyce Lee

Concepts (317)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
61
2025
638
12.440
 Why?
Idiopathic Pulmonary Fibrosis
61
2025
657
11.780
 Why?
Arthritis, Rheumatoid
23
2025
1167
4.330
 Why?
Scleroderma, Systemic
10
2025
122
2.550
 Why?
Immunosuppressive Agents
8
2025
890
1.940
 Why?
Connective Tissue Diseases
9
2021
84
1.790
 Why?
Mucin-5B
5
2025
224
1.630
 Why?
Lung
26
2025
4060
1.620
 Why?
Autoimmune Diseases
11
2025
460
1.570
 Why?
Vital Capacity
15
2025
311
1.370
 Why?
Gastroesophageal Reflux
5
2020
234
1.300
 Why?
Rheumatic Diseases
5
2024
81
1.290
 Why?
Tomography, X-Ray Computed
24
2025
2691
1.280
 Why?
Disease Progression
12
2024
2757
1.270
 Why?
Pulmonary Fibrosis
10
2025
402
1.220
 Why?
Prognosis
22
2024
4030
1.050
 Why?
Alveolitis, Extrinsic Allergic
6
2022
97
1.020
 Why?
Humans
122
2025
137585
0.980
 Why?
Respiratory Aspiration
4
2020
31
0.970
 Why?
Quality of Life
4
2024
2892
0.880
 Why?
Idiopathic Interstitial Pneumonias
4
2019
49
0.880
 Why?
Aged
48
2025
23961
0.840
 Why?
Middle Aged
51
2025
33479
0.840
 Why?
Biomarkers
11
2025
4149
0.830
 Why?
Telomerase
2
2023
250
0.790
 Why?
Pulmonary Surfactants
1
2023
106
0.780
 Why?
Cryptogenic Organizing Pneumonia
1
2022
19
0.760
 Why?
Histamine H2 Antagonists
2
2013
30
0.760
 Why?
Glucocorticoids
3
2024
594
0.750
 Why?
Matrix Metalloproteinase 7
1
2021
26
0.740
 Why?
Telomere
2
2024
280
0.740
 Why?
Proton Pump Inhibitors
2
2013
109
0.710
 Why?
Proteomics
3
2025
1111
0.690
 Why?
Rheumatology
5
2024
118
0.680
 Why?
Male
64
2025
67762
0.670
 Why?
Respiratory Function Tests
10
2025
600
0.670
 Why?
Adrenal Cortex Hormones
3
2021
565
0.660
 Why?
Diagnosis, Differential
9
2025
1483
0.640
 Why?
Lung Transplantation
9
2025
313
0.630
 Why?
Cellular Senescence
1
2021
189
0.620
 Why?
Female
63
2025
73304
0.610
 Why?
Myositis
3
2024
52
0.580
 Why?
Prospective Studies
12
2025
7604
0.530
 Why?
Patient Satisfaction
2
2021
660
0.510
 Why?
Dyspnea
5
2023
254
0.500
 Why?
Forecasting
1
2017
389
0.490
 Why?
Risk Assessment
10
2021
3457
0.480
 Why?
Severity of Illness Index
8
2018
2828
0.460
 Why?
Survival Rate
10
2020
1972
0.450
 Why?
Longitudinal Studies
8
2017
2844
0.440
 Why?
Cohort Studies
13
2025
5742
0.430
 Why?
Genetic Predisposition to Disease
2
2022
2426
0.420
 Why?
Patient Education as Topic
2
2016
766
0.420
 Why?
Azathioprine
2
2024
54
0.410
 Why?
Pulmonary Diffusing Capacity
5
2020
75
0.400
 Why?
Precision Medicine
1
2017
429
0.400
 Why?
Rituximab
2
2024
176
0.390
 Why?
Hypertension, Pulmonary
3
2022
1910
0.380
 Why?
Pepsin A
1
2011
19
0.370
 Why?
Antirheumatic Agents
4
2024
293
0.370
 Why?
Comprehensive Health Care
1
2011
24
0.360
 Why?
Fundoplication
1
2011
53
0.350
 Why?
Sleep Apnea, Obstructive
1
2015
293
0.350
 Why?
Veterans
4
2023
1476
0.340
 Why?
Carbon Monoxide
4
2019
81
0.330
 Why?
Telomere Shortening
2
2024
20
0.330
 Why?
Bronchoalveolar Lavage Fluid
2
2011
652
0.320
 Why?
Endotoxins
1
2010
220
0.320
 Why?
Proportional Hazards Models
7
2024
1266
0.320
 Why?
Sirolimus
1
2011
276
0.310
 Why?
Forced Expiratory Volume
4
2025
531
0.310
 Why?
Anti-Bacterial Agents
1
2019
1809
0.310
 Why?
Phenotype
6
2025
3196
0.300
 Why?
United States
17
2025
14841
0.300
 Why?
Retrospective Studies
16
2024
15657
0.290
 Why?
Emphysema
2
2022
106
0.280
 Why?
Acute Lung Injury
1
2010
287
0.270
 Why?
Mycophenolic Acid
3
2024
117
0.270
 Why?
Lung Diseases
3
2020
767
0.270
 Why?
Comorbidity
5
2015
1622
0.260
 Why?
Depression
1
2015
1397
0.250
 Why?
Prevalence
5
2022
2734
0.250
 Why?
Autoantibodies
2
2015
1496
0.240
 Why?
Predictive Value of Tests
4
2017
2031
0.240
 Why?
Pyridones
2
2024
168
0.240
 Why?
Pulmonologists
1
2025
14
0.230
 Why?
Mutation
3
2023
3958
0.230
 Why?
Sex Factors
4
2020
2071
0.230
 Why?
Aged, 80 and over
10
2024
7635
0.230
 Why?
Endothelium, Vascular
1
2010
927
0.220
 Why?
Abatacept
1
2024
53
0.220
 Why?
Case-Control Studies
6
2021
3556
0.220
 Why?
Biopsy, Needle
3
2019
189
0.210
 Why?
Spirometry
3
2025
281
0.210
 Why?
Chronic Disease
6
2020
1793
0.210
 Why?
Pulmonary Emphysema
2
2025
288
0.210
 Why?
Blood Proteins
1
2025
252
0.200
 Why?
Sputum
1
2025
311
0.200
 Why?
Indoles
2
2024
412
0.200
 Why?
Polychlorinated Dibenzodioxins
1
2022
7
0.200
 Why?
Transforming Growth Factor beta
1
2025
480
0.190
 Why?
Fibrosis
3
2022
552
0.190
 Why?
Genotype
2
2025
1916
0.190
 Why?
Genetic Testing
1
2025
460
0.180
 Why?
Self Care
2
2017
380
0.180
 Why?
Monocytes
2
2021
563
0.180
 Why?
Organizational Objectives
1
2021
73
0.180
 Why?
Incidence
5
2023
2804
0.180
 Why?
Societies, Medical
5
2025
820
0.170
 Why?
Genetic Markers
1
2022
344
0.170
 Why?
Nursing Research
1
2021
50
0.170
 Why?
Early Diagnosis
1
2022
242
0.170
 Why?
Adult
17
2025
37929
0.170
 Why?
Kaplan-Meier Estimate
5
2017
889
0.170
 Why?
Treatment Outcome
6
2025
10811
0.170
 Why?
Patient Outcome Assessment
1
2021
131
0.170
 Why?
Chemokine CX3CL1
1
2020
24
0.160
 Why?
Disease Models, Animal
1
2010
4295
0.160
 Why?
Survival Analysis
3
2012
1325
0.160
 Why?
Smoking
3
2024
1627
0.160
 Why?
Immunohistochemistry
3
2019
1738
0.160
 Why?
Disease Management
4
2018
628
0.160
 Why?
Models, Organizational
1
2020
151
0.160
 Why?
Myositis, Inclusion Body
1
2019
11
0.160
 Why?
Risk Factors
9
2025
10388
0.150
 Why?
Radiography
2
2011
822
0.150
 Why?
Wnt-5a Protein
1
2018
23
0.150
 Why?
Graft Rejection
2
2020
624
0.150
 Why?
Gain of Function Mutation
1
2018
36
0.150
 Why?
Ambulatory Care Facilities
1
2020
232
0.150
 Why?
Body Weight
1
2022
985
0.140
 Why?
Immunity, Innate
1
2024
828
0.140
 Why?
Randomized Controlled Trials as Topic
1
2024
1477
0.140
 Why?
Signal Transduction
2
2023
5079
0.140
 Why?
Focus Groups
2
2020
522
0.140
 Why?
Weight Loss
1
2022
787
0.130
 Why?
International Cooperation
1
2017
198
0.130
 Why?
Myofibroblasts
1
2018
127
0.130
 Why?
Amino Acyl-tRNA Synthetases
1
2016
30
0.130
 Why?
Extracellular Vesicles
1
2018
146
0.130
 Why?
Health Status Indicators
1
2017
171
0.130
 Why?
Patient-Centered Care
1
2021
530
0.120
 Why?
Practice Patterns, Physicians'
1
2025
1313
0.120
 Why?
Tomography Scanners, X-Ray Computed
1
2015
20
0.120
 Why?
Women's Health
1
2018
372
0.120
 Why?
Acute Disease
3
2016
1007
0.120
 Why?
Follow-Up Studies
4
2019
5131
0.120
 Why?
Sarcoidosis
1
2017
159
0.120
 Why?
Cause of Death
1
2017
434
0.110
 Why?
Sleep Wake Disorders
1
2018
286
0.110
 Why?
Hospitalization
1
2025
2199
0.110
 Why?
Antibiotic Prophylaxis
1
2016
119
0.110
 Why?
Pulmonary Medicine
1
2015
85
0.110
 Why?
Nails
1
2014
12
0.110
 Why?
Hyperpigmentation
1
2014
26
0.110
 Why?
Oxygen Inhalation Therapy
1
2016
157
0.110
 Why?
Body Mass Index
1
2022
2389
0.110
 Why?
Laparoscopy
1
2018
466
0.110
 Why?
Arsenic
1
2014
64
0.100
 Why?
Bronchodilator Agents
1
2015
252
0.100
 Why?
Gene Expression Profiling
1
2020
1774
0.100
 Why?
Diagnostic Imaging
1
2016
332
0.100
 Why?
Interleukin-13
1
2014
149
0.100
 Why?
Age Factors
3
2019
3295
0.100
 Why?
Keratin-18
1
2012
10
0.100
 Why?
Counseling
1
2016
391
0.100
 Why?
Interviews as Topic
1
2016
786
0.100
 Why?
Cystic Fibrosis
1
2023
1114
0.100
 Why?
Biopsy
4
2018
1129
0.100
 Why?
Autoimmunity
2
2015
908
0.100
 Why?
Maternal Exposure
1
2014
190
0.100
 Why?
Fatigue
1
2014
329
0.090
 Why?
Sjogren's Syndrome
2
2024
54
0.090
 Why?
Age Distribution
3
2019
392
0.090
 Why?
Time Factors
2
2024
6828
0.090
 Why?
Algorithms
2
2016
1704
0.090
 Why?
Everolimus
1
2011
91
0.090
 Why?
Dermatitis, Atopic
1
2014
329
0.090
 Why?
Epithelial Cells
2
2014
1096
0.090
 Why?
Sodium-Potassium-Exchanging ATPase
1
2010
49
0.080
 Why?
Goals
1
2011
170
0.080
 Why?
Delphi Technique
2
2022
280
0.080
 Why?
Fetus
1
2014
806
0.080
 Why?
Alveolar Epithelial Cells
1
2010
114
0.080
 Why?
Qualitative Research
1
2016
1386
0.080
 Why?
Health Status
1
2014
792
0.080
 Why?
Sensitivity and Specificity
1
2013
1946
0.070
 Why?
Virus Diseases
1
2011
212
0.070
 Why?
Syndrome
2
2022
358
0.070
 Why?
Models, Statistical
1
2012
669
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2010
437
0.070
 Why?
Animals
6
2025
36940
0.070
 Why?
DNA
1
2014
1459
0.070
 Why?
Pulmonary Alveoli
2
2025
405
0.070
 Why?
Antibodies, Monoclonal
1
2014
1430
0.070
 Why?
Cell Membrane
1
2010
738
0.060
 Why?
Internationality
2
2017
155
0.060
 Why?
Mass Screening
2
2024
1287
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2025
35
0.060
 Why?
Promoter Regions, Genetic
2
2021
1250
0.060
 Why?
Methotrexate
2
2021
260
0.060
 Why?
Cyclophosphamide
1
2025
247
0.060
 Why?
Palliative Care
1
2011
758
0.060
 Why?
Mixed Connective Tissue Disease
1
2024
10
0.060
 Why?
Pandemics
2
2024
1639
0.060
 Why?
Prednisone
2
2019
240
0.060
 Why?
Sex Distribution
2
2015
375
0.050
 Why?
Walk Test
1
2024
76
0.050
 Why?
Professional Practice Gaps
1
2023
15
0.050
 Why?
Adaptive Immunity
1
2024
165
0.050
 Why?
Demography
1
2024
291
0.050
 Why?
Agent Orange
1
2022
2
0.050
 Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
2
0.050
 Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
13
0.050
 Why?
Antibody Formation
1
2024
298
0.050
 Why?
Whole Genome Sequencing
1
2023
160
0.050
 Why?
Respiratory Mucosa
1
2025
321
0.050
 Why?
Exome
1
2023
231
0.050
 Why?
Probability
1
2022
304
0.050
 Why?
Family
1
2025
671
0.040
 Why?
Bayes Theorem
1
2022
405
0.040
 Why?
CX3C Chemokine Receptor 1
1
2020
19
0.040
 Why?
Evidence-Based Medicine
1
2024
740
0.040
 Why?
Allografts
1
2020
146
0.040
 Why?
Total Lung Capacity
1
2019
33
0.040
 Why?
Mice, Inbred C57BL
1
2010
5757
0.040
 Why?
Antibodies, Viral
1
2024
625
0.040
 Why?
Drug Discovery
1
2020
142
0.040
 Why?
Fibroblasts
1
2025
996
0.040
 Why?
Immunotherapy
1
2024
641
0.040
 Why?
Insulin
1
2010
2409
0.040
 Why?
Ireland
1
2019
30
0.040
 Why?
Dermatomyositis
1
2019
27
0.040
 Why?
Echocardiography
1
2022
642
0.040
 Why?
Rare Diseases
1
2019
104
0.040
 Why?
Intention to Treat Analysis
1
2018
73
0.040
 Why?
Hydrogen-Ion Concentration
1
2020
560
0.040
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
104
0.040
 Why?
Behavior
1
2018
90
0.040
 Why?
Education
1
2018
108
0.040
 Why?
United Kingdom
1
2019
318
0.030
 Why?
Morbidity
1
2018
324
0.030
 Why?
Sleep Apnea Syndromes
1
2018
88
0.030
 Why?
Medicare
1
2023
773
0.030
 Why?
Mice
2
2014
17787
0.030
 Why?
Linear Models
1
2019
849
0.030
 Why?
Comprehension
1
2018
172
0.030
 Why?
Antibodies, Antinuclear
1
2016
71
0.030
 Why?
Muscle Strength
1
2019
317
0.030
 Why?
Flow Cytometry
1
2020
1178
0.030
 Why?
California
1
2017
431
0.030
 Why?
Odds Ratio
1
2018
1070
0.030
 Why?
Global Health
1
2018
386
0.030
 Why?
Gene Expression
1
2020
1502
0.030
 Why?
Evaluation Studies as Topic
1
2015
180
0.030
 Why?
Vaccination
1
2024
1381
0.030
 Why?
Pneumonia, Aspiration
1
2015
18
0.030
 Why?
Monitoring, Physiologic
1
2017
275
0.030
 Why?
Recovery of Function
1
2019
653
0.030
 Why?
Singapore
1
2014
22
0.030
 Why?
Bronchiolitis Obliterans
1
2015
69
0.030
 Why?
Regression Analysis
1
2017
1024
0.030
 Why?
Sampling Studies
1
2014
99
0.030
 Why?
San Francisco
1
2014
52
0.030
 Why?
Chicago
1
2014
61
0.030
 Why?
Endothelial Cells
1
2020
785
0.030
 Why?
Europe
1
2015
414
0.030
 Why?
Neck
1
2014
101
0.030
 Why?
Patient Acuity
1
2013
47
0.030
 Why?
Texas
1
2014
244
0.030
 Why?
Mice, SCID
1
2014
367
0.030
 Why?
Observational Studies as Topic
1
2013
117
0.030
 Why?
Enzyme Inhibitors
1
2016
840
0.020
 Why?
Leukocytes
1
2014
311
0.020
 Why?
Protein Kinase Inhibitors
1
2019
916
0.020
 Why?
Developing Countries
1
2014
307
0.020
 Why?
Young Adult
2
2022
13209
0.020
 Why?
Surveys and Questionnaires
1
2025
5778
0.020
 Why?
Endoplasmic Reticulum Stress
1
2012
110
0.020
 Why?
Academic Medical Centers
1
2014
512
0.020
 Why?
Torque teno virus
1
2011
1
0.020
 Why?
DNA Virus Infections
1
2011
3
0.020
 Why?
Up-Regulation
1
2014
843
0.020
 Why?
Molecular Targeted Therapy
1
2014
411
0.020
 Why?
Cells, Cultured
1
2018
4193
0.020
 Why?
Microarray Analysis
1
2011
117
0.020
 Why?
Mass Spectrometry
1
2014
739
0.020
 Why?
Multivariate Analysis
1
2014
1509
0.020
 Why?
Pulmonary Disease, Chronic Obstructive
1
2018
1040
0.020
 Why?
Models, Theoretical
1
2014
578
0.020
 Why?
Colorado
1
2020
4565
0.020
 Why?
Subcellular Fractions
1
2010
82
0.020
 Why?
Body Fluids
1
2010
66
0.020
 Why?
GTPase-Activating Proteins
1
2010
83
0.020
 Why?
Practice Guidelines as Topic
1
2017
1587
0.020
 Why?
Adolescent
2
2022
21513
0.020
 Why?
rab GTP-Binding Proteins
1
2010
75
0.020
 Why?
Inflammation
1
2020
2837
0.020
 Why?
Reproducibility of Results
1
2017
3284
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
767
0.020
 Why?
Models, Biological
1
2016
1783
0.020
 Why?
Protein Transport
1
2010
445
0.020
 Why?
Telemedicine
1
2017
862
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2010
366
0.020
 Why?
Polymerase Chain Reaction
1
2011
1062
0.020
 Why?
Sequence Analysis, DNA
1
2011
812
0.020
 Why?
Cattle
1
2010
984
0.020
 Why?
Logistic Models
1
2012
2074
0.020
 Why?
Respiratory Tract Infections
1
2011
390
0.020
 Why?
Asthma
1
2018
2295
0.010
 Why?
Rats, Sprague-Dawley
1
2010
2486
0.010
 Why?
Apoptosis
1
2012
2553
0.010
 Why?
Cross-Sectional Studies
1
2014
5472
0.010
 Why?
Pregnancy
1
2014
6763
0.010
 Why?
Rats
1
2010
5647
0.010
 Why?
Infant
1
2014
9465
0.010
 Why?
Child
1
2014
21935
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)